Solid Cancer Clinical Trial
Official title:
Evaluation of Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patients with spine metastases from any solid cancer.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03721679 -
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02884375 -
Elderly CAncer Patient
|
N/A | |
| Completed |
NCT00925743 -
A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer
|
Phase 1 | |
| Recruiting |
NCT06161025 -
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
|
Phase 2/Phase 3 | |
| Completed |
NCT02959905 -
Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
|
Phase 1 | |
| Recruiting |
NCT04248348 -
Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients
|
||
| Recruiting |
NCT03311100 -
Immunological Profile of Solid Tumors Sample
|
N/A | |
| Completed |
NCT03890731 -
A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed
|
Phase 2 |